[Effects of diphenylhydantoin on myotonia and biopsy findings of the muscle]. 1976

T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe

UI MeSH Term Description Entries
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009224 Myotonia Congenita Inherited myotonic disorders with early childhood onset MYOTONIA. Muscular hypertrophy is common and myotonia may impair ambulation and other movements. It is classified as Thomsen (autosomal dominant) or Becker (autosomal recessive) generalized myotonia mainly based on the inheritance pattern. Becker type is also clinically more severe. An autosomal dominant variant with milder symptoms and later onset is known as myotonia levior. Mutations in the voltage-dependent skeletal muscle chloride channel are associated with the disorders. Becker Generalized Myotonia,Myotonia, Generalized, Becker,Thomsen Disease,Batten Turner Congenital Myopathy,Batten-Turner Congenital Myopathy,Becker Disease,Congenital Myotonia,Generalized Myotonia of Becker,Generalized Myotonia of Thomsen,Myopathy, Congenital,Myotonia Congenita, Autosomal Dominant,Myotonia Congenita, Autosomal Recessive,Myotonia Levior,Myotonia, Generalized,Thomsen's Disease,Thomsens Disease,Disease, Becker,Disease, Thomsen,Disease, Thomsen's,Disease, Thomsens,Generalized Myotonia,Generalized Myotonia, Becker,Generalized Myotonias,Myotonia, Becker Generalized,Myotonias, Generalized,Thomsen Generalized Myotonia
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
April 1972, The New England journal of medicine,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
May 1973, Archives internationales de pharmacodynamie et de therapie,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
January 1983, European neurology,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
January 1975, Archives internationales de pharmacodynamie et de therapie,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
January 1956, Rivista di patologia nervosa e mentale,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
April 1967, Neurology,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
June 1978, Annals of neurology,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
November 2002, Rheumatic diseases clinics of North America,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
July 1977, Neurology,
T Kurihara, and S Tawara, and S Araki, and S Okamoto, and T Shirabe
November 1964, Electroencephalography and clinical neurophysiology,
Copied contents to your clipboard!